![]() CellaVision CellaVision develops and sells digital solutions for blood and body fluids analysis in health care services sector. | Caristo Diagnostics Caristo Diagnostics is a company that provides solutions for personalized cardiovascular risk prediction. | Neogia Neogia is a technology company engaged in the development of medical devices based on big data, artificial intelligence, and data security. | ||
Founding Date | Founding Date 1994 | Founding Date 2018 | Founding Date 2004 | Founding Date 2016 |
Type | Type Public | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations HQ | Locations Oulu, FI HQ Espoo, FI Tampere, FI Pleasanton, US Boston, US | Locations Paris, FR HQ Paris, FR | |
Employees | Employees 228 | Employees 552% increase | Employees 118 | Employees 1 |
Valuation ($) | Valuation ($) 551.6 m | Valuation ($) N/A | Valuation ($) 79.9 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) kr759m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) €17.1m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods kr224.8m (FY, 2025) | Cost of goods N/A | Cost of goods €6.2m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit kr534.2m (FY, 2025) | Gross profit N/A | Gross profit €10.9m (FY, 2025) | Gross profit N/A |
Net income | Net income kr153.1m (FY, 2025) | Net income N/A | Net income (€6.6m) (FY, 2025) | Net income N/A |
Caristo Diagnostics is a company that provides solutions for personalized cardiovascular risk prediction.
View companyOptomed is a medical technology company specializing in portable eye screening solutions.
View companyNeogia is a technology company engaged in the development of medical devices based on big data, artificial intelligence, and data security.
View company